Business
Alzheimer's drug Leqembi falls short of blockbuster status in faltering US rollout - Financial Times
High costs and concerns over efficacy and side effects limit uptake of first treatment as another nears approval
By: Financial Times
- Apr 23 2024
- 0
- 0 Views
Every fortnight, retired business owner Carolyn Davis drives more than 300 miles from her home in Floridas Pensacola Beach to a hospital in Atlanta, Georgia, for an hour-long infusion of a novel medi… [+7109 chars]